Paul A. Clarke
York, ENG YO105DD, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
Fragment-Based Discovery of Potent RNA-Competitive Inhibitors of the DEAH-Box RNA Helicase DHX8.
Journal: Journal of medicinal chemistry
Published: March 06, 2026
'Clip-Cycle' approaches to functionalised pyrrolidines, pyrrolizidines and indolizidines.
Journal: Organic & biomolecular chemistry
Published: December 18, 2025
Inhibition of cyclin-dependent kinase 8 modulates chondrocyte transition to hypertrophy and provides in vivo protection against spontaneous osteoarthritis.
Journal: Bone research
Published: August 21, 2025
Mediator Kinase Inhibitor Selectivity and Activity in Colorectal Cancer.
Journal: ACS chemical biology
Published: July 02, 2025
R-loop editing by DNA cytosine deaminase APOBEC3B modulates the activity of oestrogen receptor enhancers.
Journal: Nature communications
Published: March 20, 2025
Asymmetric 'Clip-Cycle' synthesis of 3-spiropiperidines.
Journal: Organic & biomolecular chemistry
Published: November 26, 2024
Stereoselective synthesis of an advanced trans-decalin intermediate towards the total synthesis of anthracimycin.
Journal: Chemical communications (Cambridge, England)
Published: May 10, 2024
Integrating fragment-based screening with targeted protein degradation and genetic rescue to explore eIF4E function.
Journal: Nature communications
Published: September 21, 2023
HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies.
Journal: Journal of medicinal chemistry
Published: April 05, 2023
Last Updated: 09/26/2026